Results 131 to 140 of about 214,511 (232)

ANTİFUNGALLERİN SİSTEMİK MANTAR İNFEKSİYONLARINDA KULLANIMI VE DUYARLILIK DENEYLERİ: GENEL YÖNLENDİRME

Cerrahpaşa Medical Journal, 2014
Background.- This paper outlines major distinctive features of conventional antifungal agents and their common practice, and also reviews various reports related to systemic antifungal prophylaxis and therapy administrations.
Ayhan YÜCEL, A. Serda KANTARCIOĞLU
doaj  

Epidemiology and treatment approaches in management of invasive fungal infections

Clinical Epidemiology, 2011
Jane Kriengkauykiat1,2, James I Ito2, Sanjeet S Dadwal21Department of Pharmacy, 2Division of Infectious Diseases, City of Hope, Duarte, CA, USAAbstract: Over the past 20 years, the number of invasive fungal infections has continued to persist, due ...
Kriengkauykiat J, Ito JI, Dadwal SS   +1 more
doaj  

Antifungal Prophylaxis in Solid Organ Transplant Recipients

Solid organ transplantation (SOT) is a treatment method that improves quality of life and survival of patients with end-stage organ failure. Immunosuppressive treatments given to these patients may predispose to the development of invasive fungal ...
Ergin, C, Metin, DY, Çetin, CB, Pullukçu, H, Avci, M, Oguz, VA, Kutlu, M, Baysan, BÖ, Yapar, N, Çavus, SA, Ertugrul, B, Kaya, O, Tasbakan, MI, Mermut, G, Turhan, Ö, Kutsoylu, OE, Öztürk, B, Kutlu, SS, Senol, S   +18 more
core  

Effectiveness of Systemic Antifungal Prophylaxis in Patients With Neutropenia After Chemotherapy: A Meta-Analysis of Randomized Controlled Trials

, 2010
Background: Invasive fungal infections are responsible for substantial morbidity and mortality among patients with neutropenia after chemotherapy. Objective: This meta-analysis was conducted to estimate the effect of systemic antifungal prophylaxis on ...
Kourbeti, I.S., Ziakas, P.D., Voulgarelis, M., Mylonakis, E.   +3 more
core   +1 more source

Practices of Antifungal Prophylaxis Among Italian Pediatric Oncology-Hematology Centers. [PDF]

EJHaem
Colli M, Grasso A, Spadea M, Compagno F, Chiusaroli L, Muggeo P, Pancaldi A, Mura R, Onofrillo D, De Santis R, Mongelli B, Barone A, Rinieri S, Coccia P, Ricci E, Faraci M, D'Amico MR, Galaverna F, Gasperini P, Brescia L, Colombini A, Masetti R, Baccelli F, Cesaro S.   +23 more
europepmc   +1 more source

Liposomal amphotericin B as an antifungal prophylaxis in bilateral lung transplantation: a safety analysis. [PDF]

BMC Pharmacol Toxicol
Boscolo A, Sella N, Congedi S, Paiusco I, Pistollato E, Zanaga A, Chiapperini F, Zarantonello F, Mormando G, Pagliarini G, De Cassai A, Pettenuzzo T, Dell'Amore A, Navalesi P.   +13 more
europepmc   +1 more source

Isavuconazole as primary antifungal prophylaxis in pediatric hematological patients: a clinical and pharmacokinetic analysis. [PDF]

Antimicrob Agents Chemother
Baccelli F, Campoli C, Colli M, Gatti M, Gottardi F, Pagano G, Venturelli F, Leardini D, Muratore E, Bossù G, Pea F, Viale P, Giannella M, Belotti T, Prete A, Masetti R.   +15 more
europepmc   +1 more source

Fusariosis in Patients With Hematologic Malignancies in the Era of Antifungal Prophylaxis. [PDF]

Transpl Infect Dis
Vega P, Bhattacharyya P, Lieberman JA, Kuczmarski TM, Yoke LH, So LM, Smith HZ, Lengermann R, Cohen S, Fredricks DN, Pergam SA.   +10 more
europepmc   +1 more source

Antifungal Prophylaxis in Haematological Patients

Klimik Dergisi/Klimik Journal, 2020
Burak Deveci, Rabin Saba
openaire   +2 more sources

Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia. [PDF]

Sci Rep, 2023
Tu S, Zhang K, Wang N, Chu J, Yang L, Xie Z.   +5 more
europepmc   +1 more source